Monday, September 28, 2020
close [x]
to:

Испытания вакцины 'Спутник V' (53)

Magnum 70
TheNewYorkTimes - Session

lightboxes

You have to log in to have access to lightboxes

 

EN_01445877_0001
EN_01445877_0001
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0002
EN_01445877_0002
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0003
EN_01445877_0003
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0004
EN_01445877_0004
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0005
EN_01445877_0005
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0006
EN_01445877_0006
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0007
EN_01445877_0007
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0008
EN_01445877_0008
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0009
EN_01445877_0009
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0010
EN_01445877_0010
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0011
EN_01445877_0011
MOSCOW, RUSSIA - SEPTEMBER 16: Deputy chief physician of the City Polyclinic No. 220 Vladimir Tereshchenko who was vaccinated earlier, introduces a digital watch which is used to track the vaccine, in Moscow, Russia on September 16, 2020. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0012
EN_01445877_0012
MOSCOW, RUSSIA - SEPTEMBER 16: Volunteer doctor Pavel Korolev who registered at the City Polyclinic No. 220 in the capital Moscow, is seen before receiving the COVID-19 vaccine candidate after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0013
EN_01445877_0013
MOSCOW, RUSSIA - SEPTEMBER 16: Volunteer doctor Pavel Korolev who registered at the City Polyclinic No. 220 in the capital Moscow, is seen after receiving the COVID-19 vaccine candidate. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0014
EN_01445877_0014
MOSCOW, RUSSIA - SEPTEMBER 16: Volunteer doctor Pavel Korolev who registered at the City Polyclinic No. 220 in the capital Moscow, is seen after receiving the COVID-19 vaccine candidate. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0015
EN_01445877_0015
MOSCOW, RUSSIA - SEPTEMBER 16: A volunteer who was vaccinated earlier, shows a digital watch which is used to track the vaccine, in Moscow, Russia on September 16, 2020. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0016
EN_01445877_0016
MOSCOW, RUSSIA - SEPTEMBER 16: Deputy chief physician of the City Polyclinic No. 220 Vladimir Tereshchenko who was vaccinated earlier, introduces a digital watch which is used to track the vaccine, in Moscow, Russia on September 16, 2020. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0017
EN_01445877_0017
MOSCOW, RUSSIA - SEPTEMBER 16: Volunteer doctor Natalia Zaharova who registered at the City Polyclinic No. 220 in the capital Moscow, is received the COVID-19 vaccine candidate after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0018
EN_01445877_0018
MOSCOW, RUSSIA - SEPTEMBER 16: Volunteer doctor Pavel Korolev who registered at the City Polyclinic No. 220 in the capital Moscow, is received the COVID-19 vaccine candidate after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0019
EN_01445877_0019
MOSCOW, RUSSIA - SEPTEMBER 16: Volunteer doctor Natalia Zaharova who registered at the City Polyclinic No. 220 in the capital Moscow, is seen receiving the COVID-19 vaccine candidate after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0020
EN_01445877_0020
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0021
EN_01445877_0021
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0022
EN_01445877_0022
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0023
EN_01445877_0023
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0024
EN_01445877_0024
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0025
EN_01445877_0025
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0026
EN_01445877_0026
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0027
EN_01445877_0027
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0028
EN_01445877_0028
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0029
EN_01445877_0029
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0030
EN_01445877_0030
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0031
EN_01445877_0031
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0032
EN_01445877_0032
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0033
EN_01445877_0033
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0034
EN_01445877_0034
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0035
EN_01445877_0035
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0036
EN_01445877_0036
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0037
EN_01445877_0037
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0038
EN_01445877_0038
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0039
EN_01445877_0039
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0040
EN_01445877_0040
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0041
EN_01445877_0041
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0042
EN_01445877_0042
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0043
EN_01445877_0043
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445877_0044
EN_01445877_0044
MOSCOW, RUSSIA - SEPTEMBER 16: A view from City Polyclinic No. 220 on September 16, 2020 in Moscow, Russia. Volunteers who registered at the City Polyclinic No. 220 in the capital Moscow, are vaccinated after the tests and final checks regarding their health conditions. The vaccine is stored in special refrigerators in polyclinics. Test studies of the Russian COVID-19 vaccine candidate Sputnik V, developed by the The Gamaleya National Center of Epidemiology and Microbiology in Russia, on humans are proceeding. President of Russia Vladimir Putin announced on August 11 that the Covid-19 vaccine candidate "Sputnik V" was registered. Sefa Karacan / Anadolu Agency/ABACAPRESS.COM
EN_01445552_0388
EN_01445552_0388
(200915) -- MOSCOW, Sept. 15, 2020 (Xinhua) -- A medical worker checks the temperature of a volunteer before inoculating her with the new COVID-19 vaccine named "Sputnik V" during the phase-3 clinical trials in Moscow, Russia, on Sept. 15, 2020. (Photo by Alexander Zemlianichenko Jr/Xinhua)
EN_01445552_0389
EN_01445552_0389
(200915) -- MOSCOW, Sept. 15, 2020 (Xinhua) -- A medical worker inoculates a volunteer with the COVID-19 vaccine named "Sputnik V" during the phase-3 clinical trials in Moscow, Russia, on Sept. 15, 2020. (Photo by Alexander Zemlianichenko Jr/Xinhua)
EN_01445552_0390
EN_01445552_0390
(200915) -- MOSCOW, Sept. 15, 2020 (Xinhua) -- A medical worker takes COVID-19 vaccine named "Sputnik V" out of a fridge during the phase-3 clinical trials in Moscow, Russia, on Sept. 15, 2020. (Photo by Alexander Zemlianichenko Jr/Xinhua)
EN_01445552_0391
EN_01445552_0391
(200915) -- MOSCOW, Sept. 15, 2020 (Xinhua) -- A medical worker shows an electronic bracelet for monitoring the health of volunteers who take part in the phase-3 clinical trials of COVID-19 vaccine named "Sputnik V" in Moscow, Russia, on Sept. 15, 2020. (Photo by Alexander Zemlianichenko Jr/Xinhua)
EN_01445552_0392
EN_01445552_0392
(200915) -- MOSCOW, Sept. 15, 2020 (Xinhua) -- Photo taken on Sept. 15, 2020 shows Russia's new COVID-19 vaccine named "Sputnik V" during the phase-3 clinical trials in Moscow, Russia. (Photo by Alexander Zemlianichenko Jr/Xinhua)
EN_01445684_0017
EN_01445684_0017
(200916) -- BEIJING, Sept. 16, 2020 (Xinhua) -- Photo taken on Sept. 15, 2020 shows Russia's new COVID-19 vaccine named "Sputnik V" during the phase-3 clinical trials in Moscow, Russia. (Photo by Alexander Zemlianichenko Jr/Xinhua)
EN_01445575_2206
EN_01445575_2206
A shot of Russia's experimental Sputnik V coronavirus vaccine is shown before its use in Moscow, Russia, on Tuesday, Sept. 15, 2020. Russian health authorities have launched advanced trials of the vaccine among 40,000 volunteers, a randomized, placebo-controlled study. (AP Photo/Alexander Zemlianichenko Jr)
EN_01445575_2208
EN_01445575_2208
A Russian medical worker prepares a shot of Russia's experimental Sputnik V coronavirus vaccine for its use in Moscow, Russia, on Tuesday, Sept. 15, 2020. Russian health authorities have launched advanced trials of the vaccine among 40,000 volunteers, a randomized, placebo-controlled study. (AP Photo/Alexander Zemlianichenko Jr)
EN_01445575_2209
EN_01445575_2209
A Russian medical worker adminsters a shot of Russia's experimental Sputnik V coronavirus vaccine in Moscow, Russia, on Tuesday, Sept. 15, 2020. Russian health authorities have launched advanced trials of the vaccine among 40,000 volunteers, a randomized, placebo-controlled study. (AP Photo/Alexander Zemlianichenko Jr)

top